Literature DB >> 7071826

Cytosine arabinoside bladder instillation therapy for bladder tumors.

H Araki, T Mishina, K Miyakoda, T Fujiwara, T Kobayashi.   

Abstract

Bladder instillation of cytosine arabinoside (CA), 400 mg in 20 ml sterilized distilled water, was performed in 30 cases of bladder tumors. The instillation was done everyday to inpatients or 3 times a week to outpatients, for a total of 20 procedures. The total effective rate was 33%. Although the effectiveness of CA bladder instillation was less than that of mitomycin C and adriamycin, the combination of CA and these drugs might be advisable. Neither general nor local side effect was observed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071826     DOI: 10.1620/tjem.136.23

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

1.  Size and location of tumors influencing the effect of bladder instillation therapy.

Authors:  H Watanabe; M Nakao; S Nakagawa; H Takada
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Development and clinical application of an AFC regimen (adriamycin, futraful, cytosine arabinoside) for superficial bladder tumors.

Authors:  T Mishina; T Kobayashi; M Maegawa; M Nakao; S Nakagawa
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer.

Authors:  Tomonori Kato; Kazushi Nomura; Fukuo Kondo; Masami Wakisaka; Akira Komiya
Journal:  ScientificWorldJournal       Date:  2015-05-21

Review 4.  Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy.

Authors:  Yasuyoshi Miyata; Hideki Sakai
Journal:  Dis Markers       Date:  2015-11-23       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.